Troutman Pepper Hamilton Sanders advised Palvella Therapeutics, Inc. on the deal. Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company, announced the initial closing of its Series...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised iECURE on the deal. iECURE, a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Civic Eagle on the deal. Civic Eagle, a technology company providing legislative data and intelligence software solutions, announced its $10 million funding round. The...
You must be a Standard 1 Year member to access this content.
Troutman Pepper advised Apnimed on the deal. Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented SK Group on the deal while Troutman Pepper Hamilton Sanders advised Center for Breakthrough Medicines. SK Inc. announced its $350 million investment in The...
You must be a Standard 1 Year member to access this content.
Troutman Pepper Hamilton Sanders LLP advised VIA on the deal. VIA, a global leader in AI and privacy-preserving software for the energy industry, has raised $10...
You must be a Standard 1 Year member to access this content.
